Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder.

Langleben DD, Monterosso J, Elman I, Ash B, Krikorian G, Austin G.

Psychiatry Res. 2006 Mar 30;141(3):315-20. Epub 2006 Mar 3.

PMID:
16516306
3.

An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.

Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J.

Expert Opin Investig Drugs. 2008 Jan;17(1):77-84. Review.

PMID:
18095920
4.

OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.

Ramos-Quiroga JA, Corominas M, Castells X, Bosch R, Casas M.

Expert Rev Neurother. 2009 Aug;9(8):1121-31. doi: 10.1586/ern.09.65. Review.

PMID:
19673602
5.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

6.

Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.

Quinn D.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S62-6. doi: 10.1097/JCP.0b013e3181744aa6. Review.

PMID:
18480679
7.

Interaction of attention and graphomotor functions in children with attention deficit hyperactivity disorder.

Lange KW, Tucha L, Walitza S, Gerlach M, Linder M, Tucha O.

J Neural Transm Suppl. 2007;(72):249-59. Review.

PMID:
17982901
8.

Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.

Anderson VR, Scott LJ.

Drugs. 2006;66(8):1117-26. Review.

PMID:
16789796
9.

Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.

Brams M, Mao AR, Doyle RL.

Postgrad Med. 2008 Sep;120(3):69-88. doi: 10.3810/pgm.2008.09.1909. Review.

PMID:
18824827
10.

[Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].

Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.

Psychiatr Pol. 2009 Mar-Apr;43(2):183-92. Review. Polish.

PMID:
19697788
11.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
12.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
13.

Prospective follow-up studies found no chromosomal mutagenicity of methylphenidate therapy in ADHD affected children.

Walitza S, Kämpf K, Oli RG, Warnke A, Gerlach M, Stopper H.

Toxicol Lett. 2010 Mar 1;193(1):4-8. doi: 10.1016/j.toxlet.2009.12.013. Epub 2009 Dec 22. Review.

PMID:
20026394
14.

Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.

Denney CB.

J Clin Child Psychol. 2001 Mar;30(1):98-109. Review.

PMID:
11294083
15.

Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis.

Coghill DR, Seth S, Pedroso S, Usala T, Currie J, Gagliano A.

Biol Psychiatry. 2014 Oct 15;76(8):603-15. doi: 10.1016/j.biopsych.2013.10.005. Epub 2013 Oct 12. Review.

PMID:
24231201
16.

Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review.

Czerniak SM, Sikoglu EM, King JA, Kennedy DN, Mick E, Frazier J, Moore CM.

Harv Rev Psychiatry. 2013 May-Jun;21(3):151-62. doi: 10.1097/HRP.0b013e318293749e. Review.

17.

Inhibition and attention deficit hyperactivity disorder.

Quay HC.

J Abnorm Child Psychol. 1997 Feb;25(1):7-13. Review.

PMID:
9093895
18.

Role of executive function in ADHD.

Swanson JM.

J Clin Psychiatry. 2003;64 Suppl 14:35-9. Review.

PMID:
14658934
19.

What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD).

Advokat C.

Neurosci Biobehav Rev. 2010 Jul;34(8):1256-66. doi: 10.1016/j.neubiorev.2010.03.006. Epub 2010 Apr 8. Review.

PMID:
20381522
20.

Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.

Kociancic T, Reed MD, Findling RL.

Expert Opin Drug Saf. 2004 Mar;3(2):93-100. Review.

PMID:
15006715
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk